AzTrials
AzTrials

Child Sexual AbuseMi BridgeNCT06133595

Mi Bridge - Motivational Interviewing to Facilitate Help-seeking Among Individuals with Sexual Interest in Children

A study testing Behavioral: MiBridge in people with Child Sexual Abuse and Pedophilia, run by Karolinska Institutet at 6 sites in 6 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The overall aim of the study is to evaluate the effectiveness of Mi Bridge to motivate high risk participants to admit to treatment. The main research question is: Is Mi Bridge, an anonymous online program based on the principles for Motivational Interviewing, effective in making high risk individuals for committing… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Child Sexual Abuse, Pedophilia
What is being tested?
Behavioral: MiBridge
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
6 sitesin 6 countries
Study dates
18 Sep 2023to 8 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Sufficient language skills: English, Swedish, Finnish, Czech, Slovak, German, or Spanish
  • Concerns about sexual interest regarding children
  • CSAM use past six month
  • High risk for committing child sexual abuse according to the SChiMRA scale

Who cannot join

  • Participants with a severe psychiatric illness (such as high acute suicide risk or severe substance abuse) will be excluded, or lack of serious intentions to participate.

Trial locations and contacts

6 sites in 6 countries.

Christoffer Rahm, MD, PhD contact

+46793393723

christoffer.rahm@ki.se

Maria Breide contact

+46735563825

maria.breide@ki.se

6 sites in 6 countries

Czechia1 site, 1 recruiting
  • National Institute of Mental Health

    Klecany

    Katerina Klapilova, Ass Profes

    Recruiting

Other trials in Czechia

Finland1 site, 1 recruiting
  • Protect Children NGO

    Helsinki

    Nina Vaarhanen-Valkonen

    Recruiting

Other trials in Finland

Germany1 site, 1 recruiting
  • University Medical Center Hamburg-Eppendorf

    Hamburg

    Peer Briken, Professor

    Recruiting

Other trials in Germany

Slovakia1 site, 1 recruiting
  • Bratislava Police Academy

    Bratislava

    Josef Metenko, Professor

    Recruiting

Other trials in Slovakia

Spain1 site, 1 recruiting
  • Universitat Jaume I

    Castellon

    Rafael Ballester, Professor

    Recruiting

Other trials in Spain

Sweden1 site, 1 recruiting
  • Centre for psychiatry research, Region Stockholm

    Stockholm

    Christoffer Rahm, MD PhD, +46793393723, christoffer.rahm@ki.se

    Christoffer Rahm, MD PhD

    Recruiting

Other trials in Sweden

About this study

Official title: A Multicenter, Waitlist Controlled, Randomized Clinical Trial of the Effectiveness of Mi Bridge, a Motivational Interviewing Intervention to Facilitate Help-seeking Among Individuals with Sexual Interest in Children

The overall aim of the study is to evaluate the effectiveness of Mi Bridge to motivate high risk participants to admit to treatment.

The main research question is:

Is Mi Bridge, an anonymous online program based on the principles for Motivational Interviewing, effective in making high risk individuals for committing child sexual abuse prone to seek treatment for problems related to sexual interest involving children at a health care facility?

Read the detailed description

The present research project aims to contribute to the further development of accessible, evidence-based and safe care for people with sexual interest in children, and that are using child sexual abuse material (CSAM), so that these people can access treatment according to their needs and level of risk, with the objective of reducing the risk for child sexual abuse and improving the health of the group.

The intervention will be available in seven languages and will be tested in six countries.

Primary research questions:

Does Mi Bridge increase the likelihood that individuals at high risk for committing child sexual abuse accept seeking treatment for problems related to sexual interest involving minors at a health care facility?

Does Mi Bridge increase participants motivation for change regarding sexual behaviors involving minors?

Secondary research questions:

Does Mi Bridge increase the intention to seek treatment in the coming month for problems related to sexual interest involving minors at a health care facility?

Does Mi Bridge decrease participants sexual interest involving children?

Does Mi Bridge significantly decreases participants past week sexual behaviors involving children?

Does Mi Bridge significantly decreases participants symptoms of depression?

Is Mi Bridge effective in reducing certain dynamic risk factors for committing child sexual abuse?

About the intervention. Mi Bridge is a series of up to five conversations between a practitioner and a study participant over three weeks to help the participants understand more about themselves and their willingness to change, and to help the participants connect with the care they need and want. The conversations are carried out as anonymous voice calls or anonymous text-based chat. Mi Bridge is based on the established and well-researched method of Motivational Interviewing, which has been shown to be effective in helping people achieve the desired changes for several lifestyle related problems.

Research subjects will be recruited through Darknet and Clearnet. Darknet refers to websites that are accessible via Tor or similar services. The intervention is provided by practitioners and researchers in the relevant countries.

Mi Bridge will be evaluated through an international multicenter study using randomized wait-list controlled design.

The research subjects will sign a written consent form on the Iterapi platform without disclosing personal data such as name or location. During the subsequent screening interview via chat or voice call on Iterapi, participation criteria are ensured, questions are answered, and the consent to participate is confirmed. The research subjects are thus admitted to the study.

After inclusion, participants answer the baseline survey which consists of validated self-assessment questionnaires with both multiple choice and free-text answers.

Weekly during, after the waitlist, and after the therapeutic intervention, research subjects answer questions to evaluate the effectiveness and safety of the interventions.

A Statistical Analysis Plan (SAP) based on pilot study is pre-registered at the OSF platform. The SAP describes sample size calculations, and planned analyses of outcome measures.

Being tested
Behavioral: MiBridge
Keywords
Child sexual abuse material, Motivational Interviewing, Evidence based treatment, Individuals with sexual interest in children
Medical subject headings
Pedophilia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavioral: MiBridgeBehavioural

    A series of five conversations over three weeks to help participants understand more about themselves and their willingness to change, and to help participants connect with the care they need and want.

Study groups in NCT06133595
Study groupRoleWhat they receive
Experimental: MiBridgeExperimentalMiBridge: A series of five conversations over three weeks to help participants understand more about themselves and their willingness to change, and to help participants connect with the care they need and want.
Receives: Behavioral: Behavioral: MiBridge
No Intervention: WaitlistNo interventionParticipants are on a waitlist which means they have no active intervention, only weekly measurements with the same questionnaires as in the active arm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motivation to seek treatment

    The Motivation to Seek Care questionnaire, item 1, which targets motivation to seek treatment for problems related to sexual interest involving children (Likert scale 1-7; higher scores indicates higher motivation).

    Measured: Pre-intervention, during the intervention, and immediately after the intervention.

  2. Motivation to make a change

    Responses on the Change Questionnaire (3 items, ordinal from 0 - 10; 0 - 30 points in total; higher score indicates more readiness to make a change related to sexual behaviors involving children).

    Measured: Pre-intervention, during the intervention, and immediately after the intervention.

Secondary outcomes (6)
  1. Plan to seek treatment coming month

    The Motivation to Seek Care questionnaire, item 2, which targets the intention to actually seek treatment during the coming month for problems related to sexual interest involving children (Y/N, coded as 1=YES, and 2=NO).

    Measured: Pre-intervention, during the intervention, and immediately after the intervention.

  2. Sexual interest involving children

    Measured by Sexual Symptom Assessment Scale (SASS)(0-48 points; higher scores indicate more interest).

    Measured: Pre-intervention, during the intervention, and immediately after the intervention.

  3. Behaviors related to sexual interest in children

    Time spent last week (hours), as self reported on the SChiMRA+ part B, item 1-4.

    Measured: Pre-intervention, during the intervention, and immediately after the intervention.

  4. Level of hypersexuality

    Scores on the HBI-19 questionnaire (Hypersexual Behavior Inventory; 19-95 points; higher scores indicate higher level of sexuality; more than 52 points indicate hypersexuality).

    Measured: Pre-intervention, during the intervention, and immediately after the intervention.

  5. Dynamic risk for committing child sexual abuse

    Scores on Acute-2007 (21 items; 0-42 points; higher scores indicate higher dynamic risk for committing child sexual abuse).

    Measured: Pre-intervention, during the intervention, and immediately after the intervention.

  6. Depressive symtoms

    Scores on the PHQ-9 questionnaire (Patient Health Questionnaire; 0-27 points; higher scores indicate more severe depressive symptoms).

    Measured: Pre-intervention, during the intervention, and immediately after the intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2023
  2. Study start18 Sep 2023
  3. Primary completion8 Oct 2024 (estimated)
  4. Study completion8 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Participants are allocated to either the Mi Bridge intervention or waitlist during the initial phase of the study and those who receive waitlist receive Mi Bridge during the second phase of the study.
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06133595
Sponsor's protocol ID
2023-02321-01-B
Other IDs
101084355-BRIDGE-ISF-2021, 2023
Acronym
Mi Bridge
Status last verified
Oct 2024
First submitted
12 Oct 2023
Last updated
10 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Behavioral: MiBridge in people with Child Sexual Abuse and Pedophilia, run by Karolinska Institutet at 6 sites in 6 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Czechia, Finland, Germany, Slovakia, Spain and 1 more country. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Christoffer Rahm, MD, PhD (+46793393723, christoffer.rahm@ki.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motivation to seek treatment (time frame: Pre-intervention, during the intervention, and immediately after the intervention.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in